GlassScriptPhysician profile
Ella Gibson
NPI 1992382543
$3,551.67
in general payments reported to CMS, 2019-2025
10 companies · $1,411 in 2025
The $1,411 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,224 · 2023: $415 · 2024: $502 · 2025: $1,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,328.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evolution Surgical, INC | $1,261.07 | 2022-2025 | |
| Innovation Technologies INC | $493.63 | 2024-2025 | Irrisept |
| Dilon Technologies, INC. | $466.57 | 2025 | Hemoblast Bellows |
| Abbvie INC. | $347.52 | 2023-2025 | |
| Axogen | $247.34 | 2025 | |
| Polynovo North America LLC | $240.72 | 2025 | Novosorb Btm |
| Shockwave Medical, INC | $143.38 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kci USA, INC. | $140.50 | 2023 | V.A.C. Veraflo |
| Stryker Corporation | $129.23 | 2023 | Variax |
| Mentor Worldwide LLC | $81.71 | 2024-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ella Gibson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.